Todd Ridky

This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: University of Pennsylvania. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Todd Ridky. Retrieved from https://idiyas.com/inventor/todd-ridky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 4 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 2.4

ph-index = 1

Company Filing History:

4 out of 2,663

University of Pennsylvania

patents

Years Active: 2022-2024

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11992478 - Methods of using androgen receptor inhibitors as cancer therapeutics (2024-05-28),

2. 11987576 - Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject (2024-05-21),

3. 11369618 - Compounds, compositions and methods for prevention and/or treatment of cancer (2022-06-28),

4. 11236074 - Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject (2022-02-01),

Title: Todd Ridky: Innovator in Cancer Therapeutics and Skin Pigmentation

Introduction

Todd Ridky is a prominent inventor based in Bryn Mawr, PA (US), known for his significant contributions to the fields of cancer therapeutics and dermatology. With a total of 4 patents, Ridky has focused on developing innovative methods and compositions that address critical health issues.

Latest Patents

Ridky's latest patents include groundbreaking methods for using androgen receptor inhibitors as cancer therapeutics. These methods involve treating cancer in subjects with a ZIP9 inhibitor, particularly benefiting male patients whose cancerous tissues do not express the nuclear androgen receptor (AR). Additionally, he has developed compositions and methods aimed at decreasing, preventing, or reversing skin pigmentation in mammals. This invention includes compounds that modulate skin pigmentation and treat disorders associated with hyperpigmentation, acting on non-canonical sex steroid hormone receptors.

Career Highlights

Todd Ridky is affiliated with the University of Pennsylvania, where he continues to advance research in his areas of expertise. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from cancer and skin disorders.

Collaborations

Ridky collaborates with notable colleagues, including Christopher Natale and Cristina Aguirre Portoles, contributing to a dynamic research environment that fosters innovation.

Conclusion

Todd Ridky's work exemplifies the intersection of scientific research and practical application in healthcare. His patents reflect a commitment to improving patient outcomes through innovative therapeutic methods.

Profile summary based on public USPTO records.